Shandong, China, October. 18, 2021 (GLOBE NEWSWIRE) – CEO- Lu Fengyu of SPO Global Inc. (OTC Pink: “SPOM”) said, I am now officially the president of Shandong Sperson Medical Group Co., Ltd., a newly owned but separate subsidiary of “SPOM”. I have met with President Ke Wei of Shenzhen Lohas Health and Wellness Technology Co., Ltd., in Jinan on October 10, 2021. The two companies officially signed a Cooperation Agreement. Together, we hope to build a manufactory of Shenzhen Lohas Health and Wellness Technology Co., Ltd in Qingdao, in order to help Shandong Sperson Hospital more and create additional Artificial intelligence opportunities for both Companies.”
Shandong Sperson Medical Group Co., Ltd., is the Holding Company of SPO Medical Investments Inc. in Canada. It aims to be a Scientific Research Hospital with the core business of stroke prevention, screening and rehabilitation of encephalopathy and full management of nursing care. At the present time, the market has been developed in Jinan (Jigang) Hot Spring Resort, Qingdao Tailong Bay Project (Jiaozhou), Yantai Ludong Hospital Brain International Center, Tai'an, Linyi and other places.
Shenzhen Lohas Health Care Technology Co., Ltd., is a large health industry intelligence platform and focused on a new type of health care industry model that integrates smart elderly care, smart medical care, and smart terminal product development and production.
At the meeting, Ke Wei, president of Lohas Group, mentioned that it will conduct in-depth cooperation with Sperson Group on the intelligent rehabilitation of hospitals. Lohas Group will develop a series of products, such as Intelligent Ward Information Integration, health care aids, smart homes, and smart nursing. Robots among other potential opportunities. It can assist Sperson Hospital to build a first-class smart ward in China, realize the interconnection of smart ward and hospital HIS, realize the Internet + comprehensive information, solve the problems of untimely information, manual errors, and non-sharing of data. The technology realizes active warning and improves medical staff Emergency response capability. Using digital management and big data analysis, the whole life cycle management of medical orders, the whole process monitoring, the history can be traced, and the big data has a basis.
Lu Fengyu, chairman of Sperson Medical Group, expressed that he hopes to build a intelligent hospitals with Lohas Group in the future, cooperate to build Qingdao Lohas intelligent production plant, and introduce advanced technologies such as intelligent rehabilitation equipment and smart wards into the hospital. Establish a new benchmark for Sperson Hospital across Shandong.
About SPO Global Inc. (OTC Pink: SPOM): SPO Global Inc. recently completed its merger with Gerpang Healthcare Group. (www.gerpanghealthcare.com). Its subsidiary, Shandong Gerpang Biotechnology Co., Ltd. is an innovative and technological private enterprise located in the pharmaceutical Valley Industrial Park of Jinan High Tech Zone. Its main business scope includes Biomedical R&D, medical information software development and sales, medical high-tech introduction, medical high-quality consumables production and sales, health care products, drugs, medical equipment consumables agency and sales. The Company will continue to grow and capture any/all opportunities that come along that happen to be a good fit for the Company and its Shareholders.
Company Disclaimers: As a Public Traded Company, within the guidlines of Federal and State Securities Law, SPO Global, Inc. may not avail itself of the Safe Harbor provisions as identified in the Private Securities Litigation Reform Act of 1995. However, SPO Global, Inc. provides the following disclaimer and warning to protect our shareholders, prospective investors and the public at large by alerting them to the risks and uncertainties involved with any investment, and the need to perform their own due diligence and assessment.
Forward-Looking Statements: This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Securities and Exchange Commission.
Company Contact: fengyoulu@gmail.com
Source: SPO Global Inc.